Insider Transactions in Q2 2024 at Verona Pharma PLC (VRNA)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 03
2024
|
Kathleen A. Rickard Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
36,248
-1.36%
|
$36,248
$1.96 P/Share
|
|
May 01
2024
|
David Zaccardelli President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
88,544
-0.56%
|
$88,544
$1.93 P/Share
|
|
May 01
2024
|
Kathleen A. Rickard Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
73,824
-2.7%
|
$73,824
$1.93 P/Share
|
|
May 01
2024
|
Mark W Hahn Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
88,544
-0.59%
|
$88,544
$1.93 P/Share
|